Biomedical subjects
D Jenkinson
Publications and source records attributed to D Jenkinson.
Antibiotics for whooping cough.
Explore the source record for details and available documents.
Hazards from the use of child-resistant drug containers.
Fifty-nine patients receiving repeat prescriptions for anti-rheumatic drugs were visited unexpectedly at home and found to have had experience with ;Snap-Safe' child-resistant containers. Forty-one (70 per cent) patients were unable to use them. Twenty-seven (46 per cent) patients adopted hazardous alternative methods of storage. Ways of reducing this problem are suggested.
Whooping cough after stopping pertussis immunisation.
Explore the source record for details and available documents.
Outbreak of whooping cough in general practice.
Explore the source record for details and available documents.
Letter: Depressed fracture in the newborn.
Explore the source record for details and available documents.
Asymptomatic bacteriuria of pregnancy in Zambia.
Explore the source record for details and available documents.
Eclampsia and social change in the tropics.
Explore the source record for details and available documents.
Effect of oral therapy for treatment and prophylaxis of anaemia of pregnancy in an urban Zambian population.
The effect of iron and folic acid tablets supplied antenatally was studied in 77 urban Zambian patients with haemoglobin levels of 70% (10.2 grams) or over at first visit. No significant difference was found between treated and untreated groups. A haemoglobin level of 80% (10.2 grams) or over at first visit was found to be no guide to the likelihood of anaemia at term. The practice of providing treatment for these patients on the basis of the haemoglobin level at first visit is of doubtful value.
Achieving high quality long-term care for elderly people: consumers' wishes and providers' responsibilities.
The organisation of long-term care for older people has major implications for all hospital and community health services. However, even health professionals have a poor understanding of the structure and purpose of long-term care and national professional bodies are still not giving enough attention to the issues involved. In the wider context, care of disabled older people has received little public debate in the UK despite the ethical, social, and financial issues involved and despite the recent major organisational changes in the health service. The past ten years have seen a huge expansion in private residential and nursing homes with a concomitant fall in NHS long-stay beds. Currently, approximately 500,000 elderly people in the UK are living in some form of long-stay care facility, and many other elderly people with multiple disabilities are being supported at home and should also be included under the umbrella of long-term care. Ensuring appropriate, equitable, and high-quality care is a responsibility not only for health and social services but also for society as a whole. This conference, organised jointly by the Royal College of Physicians, the British Geriatrics Society, and Age Concern England, with support from the Department of Health, was a much-needed and welcomed initiative. Over 200 delegates attended, consisting of doctors (geriatricians, psychiatrists, general practitioners), nurses (public and private sector), social services representatives, Department of Health representatives, managers of nursing homes, and members of charities such as Age Concern and the Relatives Association.
Are theophyllines being prescribed effectively and safely in general practice?
To investigate the attitudes and practices of GPs towards the use and monitoring of theophyllines, a questionnaire was mailed to all 479 GP principals in Nottinghamshire with one reminder to non-responders. Valid responses were obtained from 49% (236). Theophyllines were regarded as first-line or frequent second-line bronchodilators by 40% (94 of 234) of GPs in chronic bronchitis, 24% (56 of 234) in nocturnal asthma, and by 6% (15 of 234) in chronic stable asthma, although only 1% (2 of 234) of GPs regarded theophylline as strictly first-line therapy in chronic stable asthma. Theophylline levels were never checked by 76% (172 of 225) of practitioners at the start of therapy, or by 48% (110 of 231) during long-term therapy; half (110 of 217) could identify only up to 50% of a series of common factors affecting theophylline levels. There was no relationship between a score of theophylline knowledge and prescribing habits in chronic bronchitis, but doctors who checked levels scored significantly higher. Although theophyllines are being used in general practice for broadly sensible indications, this survey highlights aspects of prescribing that may be compromising both safety and effectiveness. Patients are likely to benefit if the need to check levels and the factors affecting levels become better known.